missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. CHD1L Antibody, Novus Biologicals™

CHD1L Antibody, Novus Biologicals™

Rabbit Polyclonal Antibody

£378.00

Specifications

Antigen CHD1L
Applications Western Blot
Classification Polyclonal
Conjugate Unconjugated
Form Purified
View More Specs

Products 1
Product Code Brand Quantity Price Quantity & Availability  
Product Code Brand Quantity Price Quantity & Availability  
18235884
View Documents
missing translation for 'viewProductCertificates'
Novus Biologicals
NBP1-57105 		100 μL
£378.00
100µL
View alternative products
Save Up to  »
Please to purchase this item. Need a web account? Register with us today!
Description

Description

CHD1L Polyclonal specifically detects CHD1L in Human samples. It is validated for Western Blot.
Specifications

Specifications

CHD1L
Polyclonal
Purified
RUO
ALC1, amplified in liver cancer 1, amplified in liver cancer protein 1, CHDL, chromodomain helicase DNA binding protein 1-like, chromodomain-helicase-DNA-binding protein 1-like, FLJ22530
CHD1L
IgG
Protein A purified
Western Blot
Unconjugated
Rabbit
Q9H678
9557
Synthetic peptides corresponding to CHD1L (chromodomain helicase DNA binding protein 1-like) The peptide sequence was selected from the middle region of CHD1L. Peptide sequence DALPAAEGGSRDQEEGKNHMYLFEGKDYSKEPSKEDRKSFEQLVNLQKTL.
Primary
Videos
SDS
Documents

Documents

Product Certifications
Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Thank You! Your feedback has been submitted. Fisher Scientific is always working to improve our content for you. We appreciate your feedback.